The study, called VIBRANT (Validating Benefits of Rapamycin for Reproductive Aging Treatment), is designed to measure whether the drug rapamycin can slow down aging in ovaries — but it’s not just about reproductive health. If successful, this very first controlled study of the drug rapamycin for human aging could have wide-ranging implications for helping reduce the pains of menopause, and extending the lives of people of all genders, with a cheap, once-weekly drug that’s already widely used by some cancer patients and transplant recipients.
Related: Discussion thread Women Taking Rapamycin for Enhanced Fertility / Menopause Prevention?